T 2785/17 of 23.06.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T278517.20220623
- Date of decision
- 23 June 2022
- Case number
- T 2785/17
- Online on
- 6 October 2022
- Petition for review of
- -
- Application number
- 09767050.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
- Applicant name
- Millennium Pharmaceuticals, Inc.
- Opponent name
- Generics (U.K.) Limited
Actavis Group PTC ehf
Teva Pharmaceutical Industries Ltd - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal 2020 Art 013(2)European Patent Convention Art 123(2)
- Keywords
- Amendments
Inventive step
Sufficiency of disclosure
Amendment after summons - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of claims 1 to 6 of the main request, filed during the oral proceedings of 23 June 2022, and a description possibly to be adapted thereto.